Ramipril NDC 68180-591

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-591Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0591Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68180-591-01	68180059101	100 CAPSULE in 1 BOTTLE (68180-591-01)Marketed from Nov 25, 2024
68180-591-02	68180059102	500 CAPSULE in 1 BOTTLE (68180-591-02)Marketed from Nov 25, 2024
68180-591-09	68180059109	90 CAPSULE in 1 BOTTLE (68180-591-09)Marketed from Jun 10, 2008
68180-591-10	68180059110	90 CAPSULE in 1 BOTTLE (68180-591-10)Marketed from Dec 10, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ramipril
Generic name (nonproprietary): ramipril
Active ingredients: Ramipril — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077626
Marketing start: Jun 10, 2008
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 68180-591_43bbe4ee-f918-4087-93b9-336a801a8944SPL ID 43bbe4ee-f918-4087-93b9-336a801a8944SPL set ID a8cdec12-81d1-4ef4-82c0-d05d93c37a07RxCUI 198188, 198189, 261962, 845488UNII L35JN3I7SJUPC 0368180591092, 0368180589099, 0368180590095
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180059101 followed by a unit qualifier and the quantity

Package 68180-0591-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 24, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with thiazide diuretics ( 1.1 ). In patients 55 years or older at high risk of developing a major cardiovascular event, Ramipril capsules are indicated to reduce the risk of myocardial infarction, stroke, or death from cardiovascular causes ( 2.2 ). Ramipril capsules are indicated in stable patients who have demonstrated clinical signs of congestive heart failure post-myocardial infarc…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)